Table 2. AAV pre- and post-treatment sample sizes.
time 0 | 3 months | 12 months | |
---|---|---|---|
Monocyte | 45 | 29 | 24 |
Neutrophil | 43 | 31 | 26 |
Number of AAV patients with expression and genotype data available following quality control, by cell type and time point.
time 0 | 3 months | 12 months | |
---|---|---|---|
Monocyte | 45 | 29 | 24 |
Neutrophil | 43 | 31 | 26 |
Number of AAV patients with expression and genotype data available following quality control, by cell type and time point.